Balance Sheet Details (Tables)

9 Months Ended

Sep. 30, 2020

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Schedule of Inventory

Inventory, net consisted of the following (in thousands):

	September 30,		December 31,
	2020		2019
Raw materials	$	802	$	-
Work-in-process		2,340		1,505
Finished goods		4,132		706
Total inventory, net	$	7,274	$	2,211

Property, Plant and Equipment

Property and equipment, net consisted of the following (in thousands):

	September 30,			December 31,
	2020			2019
Software	$	733		$	733
Furniture and fixtures		598			2,598
Leasehold improvements		386			14,504
Computer hardware		310			1,296
Lab equipment		-			9,665
Total property and equipment, gross		2,027			28,796
Accumulated depreciation and amortization		(1,743	)		(10,407	)
Total property and equipment, net	$	284		$	18,389

Schedule of Intangible Assets, Net

Intangible assets, net consisted of the following (in thousands):

	September 30,			December 31,
	2020			2019
Technology	$	14,000		$	-
Trade name		1,520			-
Total intangible assets, gross		15,520			-
Accumulated amortization		(259	)		-
Total intangible assets, net	$	15,261		$	-

Accrued Expenses

Accrued expenses consisted of the following (in thousands):

	September 30,		December 31,
	2020		2019
Accrued interest expense	$	3,870	$	2,692
Accrued manufacturing costs		1,449		1,339
Accrued clinical study costs		426		3,496
Accrued other		1,938		1,785
Total accrued expenses	$	7,683	$	9,312

Schedule of Other Noncurrent Liabilities

Other noncurrent liabilities consisted of the following (in thousands):

	September 30,		December 31,
	2020		2019
Accrued interest expense	$	16,909	$	12,790
Fair value of CVRs (see Note 12)		2,610		-
Paycheck Protection Program loan		2,286		-
Total other noncurrent liabilities	$	21,805	$	12,790